|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
|
US20020052311A1
(en)
*
|
1999-09-03 |
2002-05-02 |
Beka Solomon |
Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
|
|
BRPI0108676B8
(pt)
|
2000-02-24 |
2021-05-25 |
Lilly Co Eli |
anticorpos humanizados que sequestram peptídeo amilóide beta e seus usos no tratamento de condições caracterizadas por formação de placas amiloides, bem como composição farmacêutica que compreende os referidos anticorpos
|
|
JP2003516929A
(ja)
*
|
2000-06-01 |
2003-05-20 |
ニユーララブ・リミテツド |
アミロイド形成性疾患の予防および治療
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US7320790B2
(en)
|
2001-04-30 |
2008-01-22 |
Eli Lilly And Company |
Humanized antibodies
|
|
ES2437875T3
(es)
|
2001-04-30 |
2014-01-14 |
Eli Lilly And Company |
Anticuerpos humanizados que reconocen el péptido beta-amiloide
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
PT1944040E
(pt)
|
2001-08-17 |
2012-10-31 |
Univ Washington |
Método de avaliação para a doença de alzheimer
|
|
CA2477675C
(en)
*
|
2002-03-05 |
2013-05-21 |
Ramot At Tel-Aviv University Ltd. |
Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
SI1524994T1
(sl)
*
|
2002-07-19 |
2011-08-31 |
Cytos Biotechnology Ag |
Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
|
|
AT413945B
(de)
*
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
MXPA05008156A
(es)
*
|
2003-02-01 |
2005-09-30 |
Neuralab Ltd |
Inmunizacion activa para generar anticuerpos para beta-a soluble.
|
|
DE602004027348D1
(de)
|
2003-02-10 |
2010-07-08 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
PE20050627A1
(es)
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
|
US7807171B2
(en)
|
2003-07-25 |
2010-10-05 |
Ac Immune Sa |
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
|
|
US20050225165A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Naik Sanjeev M |
Brake by-wire control system
|
|
CA2571035A1
(en)
*
|
2004-06-25 |
2006-01-12 |
Id Biomedical Corporation Of Quebec |
Compositions and methods for treating neurological disorders
|
|
AT413946B
(de)
*
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
WO2006016644A1
(ja)
*
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
抗体及びその利用
|
|
EP1792911A4
(en)
*
|
2004-09-15 |
2008-09-17 |
Univ Yokohama City |
ESSENTIAL AMINO ACID SEQUENCE FOR NEUROSPECIFIC GENE EXPRESSION
|
|
US20060160161A1
(en)
*
|
2004-10-26 |
2006-07-20 |
Elan Pharmaceuticals, Inc. |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
|
GB0424563D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
|
WO2006066089A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Humanized amyloid beta antibodies for use in improving cognition
|
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1853285B1
(en)
*
|
2005-02-01 |
2011-03-16 |
Ramot at Tel-Aviv University Ltd. |
Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
SG10201404801YA
(en)
*
|
2005-12-12 |
2014-09-26 |
Ac Immune Sa |
Monoclonal antibody
|
|
US20090304726A1
(en)
*
|
2006-02-15 |
2009-12-10 |
Ramot At Tel Aviv University Ltd. |
Viral display vehicles for treating multiple sclerosis
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
NZ574188A
(en)
|
2006-07-14 |
2012-05-25 |
Ac Immune Sa |
Humanized antibody against amyloid beta
|
|
EP2054515B1
(en)
*
|
2006-07-21 |
2012-01-11 |
Ramot at Tel-Aviv University Ltd. |
Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates
|
|
US20100129354A1
(en)
*
|
2006-10-27 |
2010-05-27 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
KR20120017469A
(ko)
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
PT2121754E
(pt)
|
2007-01-18 |
2015-05-11 |
Lilly Co Eli |
Fab de beta-amilóide peguilado
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
PT2182983E
(pt)
|
2007-07-27 |
2014-09-01 |
Janssen Alzheimer Immunotherap |
Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados
|
|
RS53174B
(sr)
|
2007-10-05 |
2014-06-30 |
Genentech Inc. |
Upotreba antiamiloidnog beta antitela u slučaju oboljenja oka
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
DK2207568T3
(en)
*
|
2007-11-16 |
2017-09-18 |
Univ Rockefeller |
ANTIBODIES SPECIFIC TO THE PROTOFIBRILE FORM OF BETA AMYLOID PROTEIN
|
|
ITNA20080006A1
(it)
*
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
CA2730073A1
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
RU2011125971A
(ru)
*
|
2008-11-24 |
2012-12-27 |
Рамот Эт Тель-Авив Юниверсити Лтд. |
Способ лечения болезни паркинсона
|
|
AU2009328505B2
(en)
|
2008-12-19 |
2014-11-27 |
Panima Pharmaceuticals Ag |
Human anti-alpha-synuclein autoantibodies
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
EP2588137A1
(en)
*
|
2010-07-02 |
2013-05-08 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Fimh vaccine against urinary tract infections (uti)
|
|
RU2607368C2
(ru)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Безопасные и функциональные гуманизированные антитела
|
|
EP3527220A1
(en)
|
2010-08-12 |
2019-08-21 |
AC Immune S.A. |
Vaccine engineering
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
AR083561A1
(es)
|
2010-10-26 |
2013-03-06 |
Ac Immune Sa |
Preparacion de una construccion antigenica
|
|
HUE041391T2
(hu)
|
2011-06-23 |
2019-05-28 |
Biogen Int Neuroscience Gmbh |
Anti-alfa-szinukleinkötõ molekulák
|
|
US8877446B2
(en)
*
|
2011-08-26 |
2014-11-04 |
Korea Research Institute Of Bioscience And Biotechnology |
Method for detecting protein-protein interactions in cells
|
|
JP2012102131A
(ja)
*
|
2012-01-05 |
2012-05-31 |
Elan Pharma Internatl Ltd |
アミロイド形成性疾患の予防および治療
|
|
JP6077569B2
(ja)
*
|
2012-12-27 |
2017-02-08 |
Ｓｐｉｂｅｒ株式会社 |
親水性組換えタンパク質の抽出方法
|
|
US20150344542A1
(en)
*
|
2012-12-27 |
2015-12-03 |
Spiber Inc. |
Partial purification method for hydrophilic recombinant protein
|
|
US9102752B2
(en)
|
2013-03-15 |
2015-08-11 |
United Biomedical, Inc. |
Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
|
|
WO2014150870A2
(en)
|
2013-03-15 |
2014-09-25 |
Altria Client Services Inc. |
Bacteriophage and methods of making and using
|
|
US10065997B2
(en)
|
2013-04-25 |
2018-09-04 |
Spiber Inc. |
Polypeptide porous body and method for producing same
|
|
JP5782580B2
(ja)
|
2013-04-25 |
2015-09-24 |
Ｓｐｉｂｅｒ株式会社 |
ポリペプチドヒドロゲル及びその製造方法
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
WO2016123425A1
(en)
|
2015-01-29 |
2016-08-04 |
Altria Client Services Llc |
Endolysin from bacteriophage against geobacillus and methods of using
|
|
US9781929B2
(en)
|
2015-01-29 |
2017-10-10 |
Altria Client Services Llc |
Bacteriophage and methods of using
|
|
AU2018308088B2
(en)
|
2017-07-25 |
2025-05-29 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
IL272773B2
(en)
|
2017-08-22 |
2024-06-01 |
Biogen Ma Inc |
Pharmaceutical preparations containing anti-amyloid cell antibodies
|
|
AU2020214796A1
(en)
|
2019-01-30 |
2021-07-29 |
Truebinding, Inc. |
Anti-Gal3 antibodies and uses thereof
|
|
WO2021242776A2
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|